Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 4, 2008, Pages 552-555

  Keoluangkhot, Valy ^a,b   Green, Michael D ^c   Nyadong, Leonard ^d   Fernández, Facundo M ^d   Mayxay, Mayfong ^a,e   Newton, Paul N ^a,f  

^a MAHOSOT HOSPITAL   (Laos)

^b Francophone Institute of Tropical Medicine   (Laos)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e NATIONAL UNIVERSITY OF LAOS   (Laos)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; DOXYCYCLINE; QUININE SULFATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; LABORATORY TEST; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; TREATMENT RESPONSE;

PLASMODIUM FALCIPARUM;

EID: 45349106663     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.552     Document Type: Article

References (24)

1. Hien TT, Day NP, Nguyen HP, Nguyen TH, Pham PL, Dinh XS, Ly VC, Ha V, Waller D, Peto TE, White NJ, 1996. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335: 76-83.
2. Van Hensbroek MB, Onyiorah E, Jaffer S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood B, Kwiatkowski D, 1996. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335: 69-75.
3. Artemether-Quinine Meta-Analysis Study Group, 2001. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 95: 637-650.
4. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group, 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366: 717-725.
5. Silamut K, Newton PN, Teja-Isavadharm P, Suputtamongkol Y, Siriyanonda D, Rasameesoraj M, Pukrittayakamee S, White NJ, 2003. Comparison of antimalarial bioavailability after oral and intramuscular artemether administration in uncomplicated falciparum malaria. Antimicrob Agents Chemother 47: 3795-3798.
6. Hien TT, Davis TM, Chuong LV, Ilett KF, Sinh DX, Phu NH, Agus C, Chiswell GM, White NJ, Farrar J, 2004. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother 48: 4234-4239.
7. Mayxay M, Nair S, Sudimack D, Imwong M, Tanomsing N, Pongvongsa T, Phompida S, Phetsouvanh R, White NJ, Anderson TJC, Newton PN, 2007. Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos). Am J Trop Med Hyg 76: 245-250.
8. Newton PN, Green MD, Fernández FM, Day NP, White NJ, 2006. Counterfeit anti-infective medicines. Lancet Infect Dis 6: 602-613.
9. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NP, Greenwood BM, Nosten F, White NJ, 2006. Manslaughter by fake artesunate in Asia - Will Africa be next? PLoS Med 3: e197.
10. Newton PN, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Chotivanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ, 2001. Fake artesunate in southeast Asia. Lancet 357: 1948-1950.
11. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A, 2006. Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg 100: 1019-1024.
12. Carpenter J, 2004. A Matrix of Drug Quality Reports on USAID- Assisted Countries by the USP Drug Quality and Information Program. Available at: http://www.uspdqi.org/pubs/other/GHC-DrugQualityMatrix.pdf. Accessed December 9, 2005.
13. Anonymous, 2001. Announcement on fake (imitation) drugs. The New Light of Myanmar, Volume IX, Number 204, November 9, 2001. Available at: http://www.myanmar.gov.mm/NLM-2001/enlm/Novem9.htm#(7).
14. Atemnkeng MA, De Cock K, Plaizier-Vercammen J, 2007. Quality control of active ingredients in artemisinin-derivative anti-malarials within Kenya and DR Congo. Trop Med Int Health 12: 68-74.
15. Mayxay M, Berends M, Brockman A, Jaidee A, Nair S, Sudimack D, Pongvongsa T, Phompida S, Phetsouvanh R, Anderson TJC, White NJ, Newton PN, 2007. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos). Am J Trop Med Hyg 76: 245-250.
16. Nyadong L, Green MD, De Jesus VR, Newton PN, Fernandez FM, 2007. Reactive desorption electrospray linear ion trap mass spectrometry of last-generation counterfeit antimalarials via noncovalent complex formation. Anal Chem 79: 2150-2157.
17. World Health Organisation, 2006. WHO Guidelines for the Treat ment of Malaria. Geneva: WHO. Available at: http://www.who.int/malaria/docs/ TreatmentGuidelines2006.pdf. Accessed January 26, 2008.
18. Jackson Y, Chappuis F, Loutan L, Taylor W, 2006. Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure? Mal J 5: 81.
19. Kachur SP, Black C, Abdulla S, Goodman C, 2006. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Mal J 5: 25.
20. Looareesuwan S, Oosterhuis B, Schilizzi BM, Sollie FA, Wilairatana P, Krudsood S, Lugt Ch B, Peeters PA, Peggins JO, 2002. Dose-finding and efficacy study for i.m. artemotil (β-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. Br J Clin Pharmacol 53: 492-500.
21. Lao PDR Ministry of Health, 2005. The Manual of Uncompli cated Malaria Diagnosis and Treatment Using Combination Regimens for Provincial and District Health Staff. Published by MoH, CMPE and Global Fund to fight AIDS, Tuberculosis and Malaria. Vientiane, Lao PDR: Ministry of Health, Government of the Lao PDR (in Lao).
22. Basco LK, Ringwald P, Manene AB, Chandenier J, 1997. False chloroquine resistance in Africa. Lancet 350: 224.
23. Taylor RB, Shakoor O, Behrens RH, 1995. Drug quality, a contributor to drug resistance? Lancet 346: 122.
24. Rozendaal J, 2000. Fake antimalarials circulating in Cambodia. Mekong Malaria Forum 7: 62-69.